Format

Send to

Choose Destination
J Med Assoc Thai. 2007 Jan;90(1):179-81.

Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder.

Author information

1
Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Abstract

Hepatotoxic effect related to Ganoderma lucidum (Lingzhi) mushroom powder was first described in a patient from Hong Kong in 2004. In 2005, the authors experienced a case of fatal fulminant hepatitis associated with such a preparation. Both patients had taken other therapeutic agents and traditionally boiled Lingzhi without any toxic effect. After switching to taking Lingzhi in powder form for 1-2 months, the hepatotoxic episode occurred in both patients. The toxic role of Lingzhi powder needs close monitoring in the future, especially in combination with other drugs.

PMID:
17621752
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center